2020 Onsite

Yes, Your Study Is at Risk: Risk Mitigation Plans for Endpoints Even the best-designed studies face risk. From slow site activation to patient scheduling bottlenecks, operational hiccups can cascade into costly timeline delays. This webinar breaks down field-tested mitigation playbooks from real-world studies—so you can protect your endpoints before issues appear.

Yes, Your Study Is at Risk: Risk Mitigation Plans for Endpoints Even the best-designed studies face risk. From slow site activation to patient scheduling bottlenecks, operational hiccups can cascade into costly timeline delays. This webinar breaks down field-tested mitigation playbooks from real-world studies—so you can protect your endpoints before issues appear.

This isn’t just for “eye trials.” Oncology, endocrine, CNS, rare disease—ocular risk is showing up everywhere. Are you ready?

This free webinar isn’t just for “eye trials.” Oncology, endocrine, CNS, rare disease—ocular risk is showing up everywhere. Is your trial ready?

If enrollment is slowing, screen-fails are rising, or referral sites are backing up—you don’t have a “small issue.” You have a timeline risk. Join Jessica McKenzie, VP of Life Sciences at 20/20 Onsite, for an actionable, high-impact session on preventing avoidable misses in trials with ocular endpoints. You’ll learn how to spot early warning signals before they snowball, and how rapid point-of-need deployment can rescue your study. 🎯 Webinar: Yes, Your Study Is at Risk: Risk Mitigation Plans for Endpoints 🗓️ Date: December 10 at 12PM ET 🔗 Register here: https://lnkd.in/ghk6WwAB #ClinicalTrials #ClinicalOps #Ophthalmology #EndpointProtection #Biotech #DecentralizedTrials #2020Onsite #webinar

Point-of-need ophthalmic assessments, anywhere you need them. We are the clinical trial experts in deploying certified, point-of-need ophthalmic teams to rescue studies. 40+ Trials Stabilized | 48 States Nationwide Coverage | 85,000+ Eye Assessments Administered.